logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jing Huang

the first affiliated hospital of nanchang university
H指数:31
被引数:9,891

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fruquintinib plus sintilimab in previously bevacizumab-treated, pMMR/MSS refractory metastatic colorectal cancer: a phase 2 clinical trial

fruquintinib 联合 sintilimab 治疗既往接受过 bevacizumab 治疗、pMMR/MSS 难治性转移性结直肠癌：一项 II 期临床研究

Cancer Immunology, Immunotherapy
IF0
2025-11-200
OAAI
Wen. Zhang; Cai-Feng. Gong; Jing-Long. Huang; Tian-Yi. Liu; Yong-Kun. Sun; Zhi-Chao. Jiang; Wang. Qu; Lin. Yang; Ying. Xin; Fei-Long. Zhao; Yue-zong. Bai; Ai-Ping. Zhou
Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials

glecirasib在KRAS G12C突变实体瘤中的有效性和安全性：两项I/II期试验的合并分析

Cancer Communications
IF24.9
2025-10-020
OAAI
Jian Li; Ting Deng; Yanhong Gu; Antonio Calles Blanco; Zhihua Li; Chunmei Bai; Lin Wu; Jing Huang; Xingya Li; Yu Yao; Zhengbo Song; Yongsheng Li; Lian Liu; Ligang Xing; Wenming Wu; Julia Martínez-Pérez; Ayala Hubert; Jon Zugazagoitia; Jian Zhang; Yongsheng Wang; Yanqiu Zhao; Guilan Wen; Guohao Xia; Diansheng Zhong; Xueqin Chen; Kuirong Jiang; Andrea Wang-Gillam; Yuli Ding; Sumei Liu; Zhiyue Rao; Xinghu Liu; Lin Shen
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial

局部晚期或转移性肉瘤患者的肿瘤内溶瘤病毒OH2注射：一项1/2期临床试验

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-01-160
OA
Tan, Zhichao; Wu, Yan; Fan, Zhengfu; Gao, Tian; Ding, Sijuan; Han, Liang; Luo, Suxia; Fan, Qingxia; Shi, Jianhua; Bai, Chujie; Xue, Ruifeng; Li, Shu; Zhang, Lu; Wang, Xinyu; Jia, Ling; Zhou, Lixin; Liu, Binlei; Huang, Jing; Liu, Jiayong
Long-Term Outcome in Cervical Lymph Node-Positive Nasopharyngeal Carcinoma Following Intensity Modulated Radiation Therapy With One-Step Cervical Nodal Clinical Target Volume Delineation by Geometric-Anatomic Expansion From Nodal Gross Target Volume: A Double-Center Experience

调强放射治疗后，通过从淋巴结大体肿瘤体积几何-解剖扩展进行一步法颈淋巴结临床靶区勾画，鼻咽癌颈淋巴结阳性患者的长期预后：一项双中心研究

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2024-12-010
PRE
Guo, Qiaojuan; Huang, Jing; Xiao, Nan; Zhou, Fangyuan; Huang, Wanfang; Zhao, Shuhan; Chen, Jihong; Xu, Hanchuan; Wu, Ziyi; Zheng, Yahan; Chen, Xinlan; Pan, Jianji; Lin, Shaojun
Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study
CELL REPORTS MEDICINE
IF10.6
2023-12-011
OAAI
Zhang, Bo; Song, Yan; Luo, Suxia; Yin, Xianli; Li, Enxiao; Wang, Hui; He, Yifu; Liu, Zhihui; Fan, Qingxia; Liang, Xinjun; Shu, Yongqian; Liu, Yunpeng; Xu, Nong; Zhang, Shu; Zhuang, Zhixiang; Zhang, Jingdong; Kou, Xiaoge; Wang, Fen; Zhu, Xiaodong; Zeng, Shan; Wang, Ke; Zhong, Haijun; Li, Shengmian; Bai, Yuxian; Yu, Junyan; Dou, Yiwei; Ma, Taiyang; Liu, Qian; Huang, Jing
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

Zolbetuximab联合CAPOX治疗CLDN18.2阳性胃或胃食管交界处腺癌: 随机，3期GLOW试验

NATURE MEDICINE
IF50
2023-07-31158
OAAI
Shah, Manish A.; Shitara, Kohei; Ajani, Jaffer A.; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Lordick, Florian; Van Cutsem, Eric; Plazas, Javier Gallego; Huang, Jing; Shen, Lin; Oh, Sang Cheul; Sunpaweravong, Patrapim; Soo Hoo, Hwoei Fen; Turk, Haci Mehmet; Oh, Mok; Park, Jung Wook; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Xu, Rui-Hua
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial

一线serplulimab或安慰剂联合化疗治疗PD-L1-positive食管鳞状细胞癌: 一项随机，双盲3期试验

NATURE MEDICINE
IF50
2023-02-0271
OAAI
Song, Yan; Zhang, Bo; Xin, Dao; Kou, Xiaoge; Tan, Zhenbo; Zhang, Shu; Sun, Meili; Zhou, Jin; Fan, Min; Zhang, Ming; Song, Yongxiang; Li, Suyi; Yuan, Yuan; Zhuang, Wu; Zhang, Jingdong; Zhang, Li; Jiang, Hao; Gu, Kangsheng; Ye, Huangyang; Ke, Ying; Li, Jing; Wang, Qingyu; Zhu, Jun; Huang, Jing

研究方向

暂未获取到该数据
B
Bo Zhang
H 指数:18论文数:132被引数:1,426
Q
Qingxia Fan
H 指数:37论文数:181被引数:5,280
R
Renrong Wu
H 指数:39论文数:211被引数:5,304
Y
Ye Yang
H 指数:27论文数:120被引数:2,842
Y
Yujun Long
H 指数:12论文数:35被引数:473
J
Jingmei Xiao
H 指数:13论文数:56被引数:496
Z
Ziwei Teng
H 指数:16论文数:69被引数:893
J
Jindong Chen
H 指数:38论文数:215被引数:4,541
H
Haishan Wu
H 指数:22论文数:94被引数:1,872
H
Hongnan Mo
H 指数:21论文数:122被引数:2,416